Siemers Eric's most recent trade in Acumen Pharmaceuticals Inc was a trade of 3,219 Common Stock done at an average price of $1.6 . Disclosure was reported to the exchange on Jan. 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Acumen Pharmaceuticals Inc | Eric Siemers | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.59 per share. | 21 Jan 2025 | 3,219 | 170,298 | - | 1.6 | 5,118 | Common Stock |
| Acumen Pharmaceuticals Inc | Eric Siemers | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 100,300 | 100,300 | - | - | Employee Stock Option (right to buy) | |
| Acumen Pharmaceuticals Inc | Eric Siemers | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 66,800 | 173,517 | - | 0 | Common Stock | |
| Acumen Pharmaceuticals Inc | Eric Siemers | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.85 per share. | 03 Jan 2025 | 10,859 | 106,717 | - | 1.8 | 20,047 | Common Stock |
| Acumen Pharmaceuticals Inc | Siemers Eric | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 3.71 per share. | 18 Jan 2024 | 3,124 | 117,576 | - | 3.7 | 11,604 | Common Stock |
| Acumen Pharmaceuticals Inc | Siemers Eric | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 141,000 | 141,000 | - | - | Employee Stock Option (right to buy) | |
| Acumen Pharmaceuticals Inc | Siemers Eric | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 94,000 | 120,700 | - | 0 | Common Stock | |
| Acumen Pharmaceuticals Inc | Eric Siemers | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 120,200 | 120,200 | - | - | Employee Stock Option (right to buy) | |
| Acumen Pharmaceuticals Inc | Eric Siemers | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 26,700 | 26,700 | - | 0 | Common Stock | |
| Acumen Pharmaceuticals Inc | Eric Siemers | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 90,000 | 90,000 | - | - | Employee Stock Option (right to buy) |